Funding cuts for drug and alcohol treatment

In its response to the review, DrugScope, representing service providers, expressed a concern about the current volatility of funding. Drugscope highlighted PHE ADPH drugs alcohol commissioning 2014 the continuous drive to reassess and retender services, and the need for commissioners to understand the impact frequent tendering processes have on providers (see this post for an alternative model).